Identification
- Composition (DCI)
- sunitinib
- Manufacturer
- ISIO LABORATOIRE
- ATC code
- L01XE04
- Presentation
- Flacon de 30
- Schedule / Reimb.
- A
- Hospital price
- 4899.00 MAD
Indications
Traitement de patients atteints de carcinome rénal avancé et/ou métastatique (RCC). Traitement de patients atteints de tumeurs stromales gastro-intestinales malignes (GIST) en cas de résistance ou d'intolérance à l'imatinib. Traitement de patients atteints de carcinome neuro-endocrine du pancréas, non résécable, bien différencié, avancé et/ou métastatique (pancreatic NET).
Find an open pharmacy
On-call pharmacies near you
About JOSUNI 12.5 MG
JOSUNI 12.5 MG is marketed in Morocco by ISIO LABORATOIRE and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of JOSUNI 12.5 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about JOSUNI 12.5 MG
Answers to common questions from Moroccan patients about this drug.